Product Information
CARBIDOPA-LEVODOPA 25-250 TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.1112 per EA under NDC 00904754961. Its NADAC has been published 36 times since Oct 22, 2025.
Strength
25; 250 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904754961
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA073607On Market Since
4/28/2025
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has been published 36 times since Oct 22, 2025, and over the history we have for it it has declined 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1112 per EA |
|---|---|
| All-time high | $0.1295 (Dec 10, 2025) |
| All-time low | $0.1104 (Mar 18, 2026) |
| 52-week high | $0.1295 |
| 52-week low | $0.1104 |
| Median price | $0.1149 |
| Average price | $0.1188 |
| Largest weekly change | -5.8% (Feb 18, 2026) |
| Weeks tracked | 36 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-250 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-250 TAB, manufactured by Major Pharmaceuticals, is $0.1112 per EA (NDC 00904754961), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-250 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has declined 11.4%. It has been tracked across 36 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-250 TAB?
Since Oct 22, 2025, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has ranged from a low of $0.1104 (Mar 18, 2026) to a high of $0.1295 (Dec 10, 2025), with a median of $0.1149 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-250 TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CARBIDOPA-LEVODOPA 25-250 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 25-250 TAB?
CARBIDOPA-LEVODOPA 25-250 TAB (NDC 00904754961) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification